Eterna Therapeutics Inc.
Eterna Therapeutics Inc. (ERNA) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 9 transactions totaling $2.9M, demonstrating a bullish sentiment with $2.9M in net insider flow. The most recent transaction on Jun 21, 2025 involved a transaction of 30 shares valued at $0.
ERNA Insider Activity Summary
Who Is Buying ERNA Stock?
No significant insider buying has been recorded for ERNA in the recent period.
Who Is Selling ERNA Stock?
No significant insider selling has been recorded for ERNA in the recent period.
Is Eterna Therapeutics Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ERNA is bullish with an Insider Alignment Score of 100/100 and a net flow of $2.9M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ERNA Frequently Asked Questions
Understanding ERNA Insider Activity
Insider trading at Eterna Therapeutics Inc. (ERNA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading ERNA stock, having executed 9 transactions in the past 90 days. The most active insider is John D. Halpern (Executive), who has made 1 transactions totaling $1.1M.
Related Tools
Track Eterna Therapeutics Inc. Insider Activity
Get notified when executives and directors at ERNA file new Form 4 transactions